Abstract
Although some myokines exert their actions on other organs in a hormone–like fashion, many of them operate locally on skeletal muscle themselves. Myokines may thereby provide a feedback loop for the muscle to regulate its own growth and regeneration allowing for adaptation to exercise training. The myokine concept provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs within the muscle itself. New biotechnological patents are published based on the identification of new myokines, and these myokines and their receptors will potentially serve as pharmacological targets for treating muscle diseases, metabolic disorders and other diseases associated with muscle disuse.
Keywords: Skeletal muscle, exercise, metabolism, metabolic diseases, activity, inactivity, muscle, muscle cells, myoblasts, myocytes, myogenesis, cytokines, myokines, interleukins, IL-6, irisin, muscle wasting, muscular dystrophies, sarcopenia, patents
Recent Patents on Biotechnology
Title:Myokines in Myogenesis and Health
Volume: 6 Issue: 3
Author(s): Tora Henriksen, Charlotte Green and Bente Klarlund Pedersen
Affiliation:
Keywords: Skeletal muscle, exercise, metabolism, metabolic diseases, activity, inactivity, muscle, muscle cells, myoblasts, myocytes, myogenesis, cytokines, myokines, interleukins, IL-6, irisin, muscle wasting, muscular dystrophies, sarcopenia, patents
Abstract: Although some myokines exert their actions on other organs in a hormone–like fashion, many of them operate locally on skeletal muscle themselves. Myokines may thereby provide a feedback loop for the muscle to regulate its own growth and regeneration allowing for adaptation to exercise training. The myokine concept provides a conceptual basis and a whole new paradigm for understanding how muscles communicate with other organs within the muscle itself. New biotechnological patents are published based on the identification of new myokines, and these myokines and their receptors will potentially serve as pharmacological targets for treating muscle diseases, metabolic disorders and other diseases associated with muscle disuse.
Export Options
About this article
Cite this article as:
Henriksen Tora, Green Charlotte and Klarlund Pedersen Bente, Myokines in Myogenesis and Health, Recent Patents on Biotechnology 2012; 6 (3) . https://dx.doi.org/10.2174/1872208311206030167
DOI https://dx.doi.org/10.2174/1872208311206030167 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Promising Activity of Mammalian Target of Rapamycin Inhibitors in Hematologic Malignancies Therapy
Current Signal Transduction Therapy The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness
Current Drug Targets Look Into My Onco-forest - Review of Plant Natural Products with Anticancer Activity
Current Topics in Medicinal Chemistry Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Current Pharmaceutical Design Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole- Containing Ruthenium Complexes
Mini-Reviews in Medicinal Chemistry The Therapeutical Potential of a Novel Pterocarpanquinone LQB-118 to Target Inhibitor of Apoptosis Proteins in Acute Myeloid Leukemia Cells
Anti-Cancer Agents in Medicinal Chemistry Epigenetics and Adult Acute Myeloid Leukemia
Current Pharmacogenomics and Personalized Medicine Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Current Cancer Drug Targets Flavonoids in Human Health: From Structure to Biological Activity
Current Nutrition & Food Science A Discussion of MicroRNAs in Cancers
Current Bioinformatics Studies on Structures and Functions of Kinases leading to Prostate Cancer and Their Inhibitors
Current Enzyme Inhibition Biodegradable Nanoparticles: A Recent Approach and Applications
Current Drug Targets The Role of Tumor Suppressor DLC-1: Far From Clear
Anti-Cancer Agents in Medicinal Chemistry Stem Cell Transplantation for Chronic Myeloid Leukemia (CML): Current Indications and Perspectives
Current Cancer Drug Targets Cancer and Aids: New Trends in Drug Design and Chemotherapy
Current Computer-Aided Drug Design Synergistic Activities of a Silver(I) Glutamic Acid Complex and Reactive Oxygen Species (ROS): A Novel Antimicrobial and Chemotherapeutic Agent
Current Medicinal Chemistry Signal Transduction Pathways and Transcription Factors as Therapeutic Targets in Inflammatory Disease: Towards Innovative Antirheumatic Therapy
Current Pharmaceutical Design Development of Lymphatic Vessels: Tumour Lymphangiogenesis and Lymphatic Invasion
Current Medicinal Chemistry Heptahelical Receptors for Lysolipids in Lymphocytes as Targets for Therapeutic Intervention
Drug Design Reviews - Online (Discontinued) Current Progresses in Metal-based Anticancer Complexes as Mammalian TrxR Inhibitors
Anti-Cancer Agents in Medicinal Chemistry